Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
about
An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cellsLAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signalingReport on the use of non-clinical studies in the regulatory evaluation of oncology drugsRNA interference and potential therapeutic applications of short interfering RNAsAnti-neoplastic efficacy of Haimiding on gastric carcinoma and its mechanismsInvolvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells.Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis.Miniature Dielectric Barrier Discharge Nonthermal Plasma Induces Apoptosis in Lung Cancer Cells and Inhibits Cell MigrationSelective cytotoxicity of Ponciri Fructus against glucose-deprived PANC-1 human pancreatic cancer cells via blocking activation of GRP78.RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy.Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrinDown-regulation of telomerase activity and activation of caspase-3 are responsible for Tanshinone I-induced apoptosis in monocyte leukemia cells in vitroTRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases.Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analoguesComparison of caspase-3 activation in tumor cells upon treatment of chemotherapeutic drugs using capillary electrophoresis.CaMKII Inhibitor KN-62 Blunts Tumor Response to Hypoxia by Inhibiting HIF-1α in Hepatoma Cells.Tumor xenograft uptake of a pyrrole-imidazole (Py-Im) polyamide varies as a function of cell line grafted.Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancerRole of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning.Free radical theory of autoimmunityEpstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.Nuclear proteomics with XRCC3 knockdown to reveal the development of doxorubicin-resistant uterine cancer.Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.Hybridized doxorubicin-Au nanospheres exhibit enhanced near-infrared surface plasmon absorption for photothermal therapy applications.Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells.Schisandrin B inhibits the proliferation of human lung adenocarcinoma A549 cells by inducing cycle arrest and apoptosis.Drug resistance in glioblastoma: a mini reviewSelective inhibition of EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent anti-tumor activity in breast cancer.Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporterProteomic approaches for studying chemoresistance in cancer.Targeting the cancer cell cycle by cold atmospheric plasmaThe therapeutic potential of RNA interference.Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assayBroad targeting of resistance to apoptosis in cancer.Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells.REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer.Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.
P2860
Q21245772-8938C40C-D841-4011-BC82-EF66390E0C2BQ24296238-999EAABC-A6B4-429B-8055-967E515B233BQ24337691-B4C3FE2E-9179-4F61-9C53-26AFE1E213BBQ26766039-CABA356F-83F5-43B3-A2C3-CE266EDECFBCQ28250480-BBEC1204-461F-4048-98CE-B7B1244F65F1Q33198297-7F89FB65-947D-4ADD-8E99-F8A8967B891EQ33226642-CEBEC93C-BB1E-4D17-B03A-A04188AE6632Q33423866-E94550DB-A8B8-480F-AFC6-7DC6324671C0Q33469924-9FC6CFEC-98ED-4850-BB2D-F6705344C3B0Q33508992-AACB674C-B3CD-4D9F-BA6F-F6DAF4C029D1Q33805534-E8476871-35A8-4C80-92CA-00EB133D8E24Q33947942-1F9560FA-FFE1-4607-8008-7E5380EA903EQ33998780-21EA9BDC-B53C-4326-8E40-00137EEAD905Q34053698-896FF97E-34D8-4AB0-9A95-A9C26C1ACDBCQ34153747-69C292A3-D2A9-40ED-B8C4-D22CB324A351Q34243306-805E57BF-B1BA-407D-B6FD-429D5635FD9FQ34382055-E34BD3D1-F427-4005-A9B0-C9A00D3D7665Q34394131-1A48501A-5A50-41AB-9F08-512A59D10FD2Q34460758-C26655B7-154E-4D1A-91EA-52D0E84E7622Q34610733-1D233810-4440-48D7-A717-15FE10D8A184Q34786280-D780205D-414E-4D97-8065-C44CCC333EABQ35032548-4AB9FA39-888B-412A-8980-088050626766Q35106014-72BAF548-FFB6-4765-8768-9FE2E149F92FQ35133116-AFBABC5E-F582-4AFC-830D-4F3438ADCFB0Q35136562-3934671F-52AF-4FF3-ABDA-2F455205B637Q35574749-9346DF8E-7A8E-4858-AF16-E6E969504480Q35578037-E65F5EBD-F6EB-4BD7-82DA-789B50B0A445Q35759931-18FF4F10-C2BF-481F-99CB-F953AAC79BC8Q35870634-751E3392-266C-422B-B44C-68537A593842Q35899534-E3BE90CA-7888-4A65-8028-C883242DC329Q35921549-E03213F8-A43C-407F-B6BA-EA3011F6B671Q36021057-41B31AC9-4E01-4E47-9A85-C06741B0DF69Q36126469-3FF14EC1-CE63-404B-BCF3-484945F3883BQ36210563-EFB0DDB0-2E39-4DFA-86A2-7ABAEDE49D16Q36237868-A3C2FC0E-FC3C-47E4-B36B-6835B118F50DQ36270038-A2881F2D-4A7C-4842-97A3-4859276E60E7Q36483749-0F04035A-7261-4FF4-BE7D-9C2ACC182E1DQ36591295-263BA2A5-7821-448B-8BD7-D4F18DC87F6CQ36594051-4B4929A5-8293-4BCE-8893-3036884CBF2DQ36741693-208C92CE-B389-478A-A8B1-0495FE85422C
P2860
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
@ast
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
@en
type
label
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
@ast
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
@en
prefLabel
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
@ast
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
@en
P2093
P2860
P1433
P1476
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
@en
P2093
Akihiro Tomida
Hiroshi Sakamoto
Mikihiko Naito
Naomi Haga
Naoya Fujita
Takashi Tsuruo
Tetsuo Mashima
P2860
P356
10.1111/J.1349-7006.2003.TB01345.X
P577
2003-01-01T00:00:00Z